Shedding of tissue factor (TF)‐containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells
- 10 November 2004
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (11) , 2065-2067
- https://doi.org/10.1111/j.1538-7836.2004.00972.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic proteinNature Medicine, 2003
- Intravascular tissue factor initiates coagulation via circulating microvesicles and plateletsThe FASEB Journal, 2003
- Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activationBlood, 2001
- The Hemostatic System and Angiogenesis in MalignancyNeoplasia, 2001
- Tissue Factor on the LooseSeminars in Thrombosis and Hemostasis, 2000
- Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma CellsPublished by Elsevier ,1997
- Extrinsic-pathway activation in cancer with high factor Vlla and tissue factorThe Lancet, 1995
- Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigensClinical & Experimental Metastasis, 1995
- The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles.Journal of Biological Chemistry, 1983